Literature DB >> 29061749

Heteroresistance to Piperacillin-Tazobactam in Clinical Isolates of Escherichia coli Sequence Type 131.

Ángel Rodríguez-Villodres1, José Manuel Ortiz de la Rosa1, Rocío Álvarez-Marín1, Jerónimo Pachón1,2, Javier Aznar1,3, José Antonio Lepe1, Younes Smani4.   

Abstract

Entities:  

Keywords:  Escherichia coli; ST131; heteroresistance; piperacillin-tazobactam

Mesh：

Substances：

Year:  2017        PMID： 29061749      PMCID： PMC5740306          DOI： 10.1128/AAC.01923-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  6 in total

1.  Impact of carbapenem heteroresistance among clinical isolates of invasive Escherichia coli in Chongqing, southwestern China.

Authors:  J D Sun; S F Huang; S S Yang; S L Pu; C M Zhang; L P Zhang
Journal:  Clin Microbiol Infect       Date:  2014-12-26       Impact factor: 8.067

Review 2.  Antimicrobial heteroresistance: an emerging field in need of clarity.

Authors:  Omar M El-Halfawy; Miguel A Valvano
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

3.  Beta-lactamases in ampicillin-resistant Escherichia coli isolates from foods, humans, and healthy animals.

Authors:  Laura Briñas; Myriam Zarazaga; Yolanda Sáenz; Fernanda Ruiz-Larrea; Carmen Torres
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

4.  Piperacillin/tazobactam-heteroresistant Pseudomonas aeruginosa from urinary infection, successfully treated by piperacillin/tazobactam.

Authors:  Spyros Pournaras; Alexandros Ikonomidis; Evangelia Neou; Maria Kantzanou; Antonios N Maniatis; Athanassios Tsakris
Journal:  J Antimicrob Chemother       Date:  2008-01-15       Impact factor: 5.790

5.  Epidemiological and clinical features for cefepime heteroresistant Escherichia coli infections in Southwest China.

Authors:  W Ma; J Sun; S Yang; L Zhang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-27       Impact factor: 3.267

6.  Sex and virulence in Escherichia coli: an evolutionary perspective.

Authors:  Thierry Wirth; Daniel Falush; Ruiting Lan; Frances Colles; Patience Mensa; Lothar H Wieler; Helge Karch; Peter R Reeves; Martin C J Maiden; Howard Ochman; Mark Achtman
Journal:  Mol Microbiol       Date:  2006-06       Impact factor: 3.501
  6 in total
  2 in total

1.  Phylogeny, Resistome, and Virulome of Escherichia coli Causing Biliary Tract Infections.

Authors:  Ángel Rodríguez-Villodres; Rémy A Bonnin; José Manuel Ortiz de la Rosa; Rocío Álvarez-Marín; Thierry Naas; Javier Aznar; Jerónimo Pachón; José Antonio Lepe; Younes Smani
Journal:  J Clin Med       Date:  2019-12-02       Impact factor: 4.241

2.  Ultrasensitive and rapid identification of ESRI developer- and piperacillin/tazobactam-resistant Escherichia coli by the MALDIpiptaz test.

Authors:  Angel Rodríguez Villodres; Lydia Gálvez Benítez; Manuel J Arroyo; Gema Méndez; Luis Mancera; Andrea Vila Domínguez; José Antonio Lepe Jímenez; Younes Smani
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 19.568
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.